Revvity | PKI - Sales Revenues


Revvity reported $711M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Agilent USD 1.84B 37M Mar/2026
Align Technology USD 1.04B 10M Mar/2026
Bio Techne USD 311.4M 15.5M Mar/2026
Bio-Rad Laboratories USD 592.1M 101.1M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Celltrion KRW 1.15T 180B Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 880M 81M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 28.31B 2.27B Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Illumina USD 1.09B 70M Mar/2026
Intuitive Surgical USD 2.77B 100M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Kangmei Pharma CNY 1.08B 288.27M Mar/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Laboratory Of America USD 3.54B 20M Mar/2026
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Mettler Toledo International USD 947.13M 182.87M Mar/2026
Myriad Genetics USD 200.4M 9.4M Mar/2026
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Pharma Mar EUR 42.9M 47.3M Mar/2026
Qiagen NV USD 419.22M 38.16M Mar/2026
Quest Diagnostics USD 2.9B 90M Mar/2026
Quidel USD 620M 104M Mar/2026
Repligen USD 194M 3.91M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Sartorius EUR 899.1M 28.5M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Tilray USD 217.51M 74.75M Dec/2025
Waters USD 1.27B 338M Mar/2026
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026